| Authors: |
Matasar M; Rutgers Cancer Institute, New Brunswick, NJ., Li Z; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, China., Vassilakopoulos TP; National and Kapodistrian University of Athens, Laikon General Hospital, Athens, Greece., Sancho JM; ICO-IJC-HU Germans Trias i Pujol, Barcelona, Spain., Viardot A; Department of Internal Medicine III, University Hospital, Ulm, Germany., McMillan A; Center for Clinical Haematology, Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom., Dal MS; University of Health Science, Ankara Oncology Training and Research Hospital, Department of Internal Medicine, Division of Hematology and Stem Cell Transplant Center, Ankara, Turkey., Pereira J; Hospital das Clinicas FMUSP, São Paulo, Brazil., Kim JS; Severance Hospital, Yonsei University Health System, Seoul, South Korea., Qiu L; National Clinical Research Center for Hematological Disorders and State Key Laboratory of Experimental Hematology, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences, Tianjin, China., Batlevi CL; Genentech, Inc, South San Francisco, CA., Ibrahim R; Genentech, Inc, South San Francisco, CA., Hernandez J; F. Hoffmann-La Roche Ltd, Basel, Switzerland., McCall B; Genentech, Inc, South San Francisco, CA., Jiang Y; Genentech, Inc, South San Francisco, CA., Yan M; Hoffmann-La Roche Ltd, Mississauga, ON, Canada., Harris W; Genentech, Inc, South San Francisco, CA., Musick L; Genentech, Inc, South San Francisco, CA., Haioun C; Lymphoid Malignancies Department, Henri Mondor University Hospital, Créteil Cedex, France. |
